Global VLP Vaccines Supply, Demand and Key Producers, 2024-2030

Description

The global VLP Vaccines market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

VLP vaccines are a type of recombinant vaccine, but they offer the efficiency of a live-attenuated vaccine. Recombinant vaccines use a particular piece of the germ that the immune system targets specifically.

This report studies the global VLP Vaccines production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for VLP Vaccines, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of VLP Vaccines that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global VLP Vaccines total production and demand, 2019-2030, (K Doses)
Global VLP Vaccines total production value, 2019-2030, (USD Million)
Global VLP Vaccines production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Doses)
Global VLP Vaccines consumption by region & country, CAGR, 2019-2030 & (K Doses)
U.S. VS China: VLP Vaccines domestic production, consumption, key domestic manufacturers and share
Global VLP Vaccines production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Doses)
Global VLP Vaccines production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Doses)
Global VLP Vaccines production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Doses).

This reports profiles key players in the global VLP Vaccines market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medicago, Novavax, Saiba Animal Health, VBI, ARTES Biotechnology, VLP Therapeutics, POSVAX, Spybiotech and Optipharm Co. Ltd, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World VLP Vaccines market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Doses) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global VLP Vaccines Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global VLP Vaccines Market, Segmentation by Type
    HPV Vaccine
    Covid-19 Vaccine
    Hepatitis B Vaccine
    Others

Global VLP Vaccines Market, Segmentation by Application
    Government
    Medical Institution
    Others

Companies Profiled:
    Medicago
    Novavax
    Saiba Animal Health
    VBI
    ARTES Biotechnology
    VLP Therapeutics
    POSVAX
    Spybiotech
    Optipharm Co. Ltd
    H&Z Life Science
    Gproan
    Merck

Key Questions Answered
1. How big is the global VLP Vaccines market?
2. What is the demand of the global VLP Vaccines market?
3. What is the year over year growth of the global VLP Vaccines market?
4. What is the production and production value of the global VLP Vaccines market?
5. Who are the key producers in the global VLP Vaccines market?

Table of Contents

1 Supply Summary
    1.1 VLP Vaccines Introduction
    1.2 World VLP Vaccines Supply & Forecast
        1.2.1 World VLP Vaccines Production Value (2019 & 2023 & 2030)
        1.2.2 World VLP Vaccines Production (2019-2030)
        1.2.3 World VLP Vaccines Pricing Trends (2019-2030)
    1.3 World VLP Vaccines Production by Region (Based on Production Site)
        1.3.1 World VLP Vaccines Production Value by Region (2019-2030)
        1.3.2 World VLP Vaccines Production by Region (2019-2030)
        1.3.3 World VLP Vaccines Average Price by Region (2019-2030)
        1.3.4 North America VLP Vaccines Production (2019-2030)
        1.3.5 Europe VLP Vaccines Production (2019-2030)
        1.3.6 China VLP Vaccines Production (2019-2030)
        1.3.7 Japan VLP Vaccines Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 VLP Vaccines Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 VLP Vaccines Major Market Trends

2 Demand Summary
    2.1 World VLP Vaccines Demand (2019-2030)
    2.2 World VLP Vaccines Consumption by Region
        2.2.1 World VLP Vaccines Consumption by Region (2019-2024)
        2.2.2 World VLP Vaccines Consumption Forecast by Region (2025-2030)
    2.3 United States VLP Vaccines Consumption (2019-2030)
    2.4 China VLP Vaccines Consumption (2019-2030)
    2.5 Europe VLP Vaccines Consumption (2019-2030)
    2.6 Japan VLP Vaccines Consumption (2019-2030)
    2.7 South Korea VLP Vaccines Consumption (2019-2030)
    2.8 ASEAN VLP Vaccines Consumption (2019-2030)
    2.9 India VLP Vaccines Consumption (2019-2030)

3 World VLP Vaccines Manufacturers Competitive Analysis
    3.1 World VLP Vaccines Production Value by Manufacturer (2019-2024)
    3.2 World VLP Vaccines Production by Manufacturer (2019-2024)
    3.3 World VLP Vaccines Average Price by Manufacturer (2019-2024)
    3.4 VLP Vaccines Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global VLP Vaccines Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for VLP Vaccines in 2023
        3.5.3 Global Concentration Ratios (CR8) for VLP Vaccines in 2023
    3.6 VLP Vaccines Market: Overall Company Footprint Analysis
        3.6.1 VLP Vaccines Market: Region Footprint
        3.6.2 VLP Vaccines Market: Company Product Type Footprint
        3.6.3 VLP Vaccines Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: VLP Vaccines Production Value Comparison
        4.1.1 United States VS China: VLP Vaccines Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: VLP Vaccines Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: VLP Vaccines Production Comparison
        4.2.1 United States VS China: VLP Vaccines Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: VLP Vaccines Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: VLP Vaccines Consumption Comparison
        4.3.1 United States VS China: VLP Vaccines Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: VLP Vaccines Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based VLP Vaccines Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based VLP Vaccines Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers VLP Vaccines Production Value (2019-2024)
        4.4.3 United States Based Manufacturers VLP Vaccines Production (2019-2024)
    4.5 China Based VLP Vaccines Manufacturers and Market Share
        4.5.1 China Based VLP Vaccines Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers VLP Vaccines Production Value (2019-2024)
        4.5.3 China Based Manufacturers VLP Vaccines Production (2019-2024)
    4.6 Rest of World Based VLP Vaccines Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based VLP Vaccines Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers VLP Vaccines Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers VLP Vaccines Production (2019-2024)

5 Market Analysis by Type
    5.1 World VLP Vaccines Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 HPV Vaccine
        5.2.2 Covid-19 Vaccine
        5.2.3 Hepatitis B Vaccine
        5.2.4 Others
    5.3 Market Segment by Type
        5.3.1 World VLP Vaccines Production by Type (2019-2030)
        5.3.2 World VLP Vaccines Production Value by Type (2019-2030)
        5.3.3 World VLP Vaccines Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World VLP Vaccines Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Government
        6.2.2 Medical Institution
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World VLP Vaccines Production by Application (2019-2030)
        6.3.2 World VLP Vaccines Production Value by Application (2019-2030)
        6.3.3 World VLP Vaccines Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Medicago
        7.1.1 Medicago Details
        7.1.2 Medicago Major Business
        7.1.3 Medicago VLP Vaccines Product and Services
        7.1.4 Medicago VLP Vaccines Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Medicago Recent Developments/Updates
        7.1.6 Medicago Competitive Strengths & Weaknesses
    7.2 Novavax
        7.2.1 Novavax Details
        7.2.2 Novavax Major Business
        7.2.3 Novavax VLP Vaccines Product and Services
        7.2.4 Novavax VLP Vaccines Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Novavax Recent Developments/Updates
        7.2.6 Novavax Competitive Strengths & Weaknesses
    7.3 Saiba Animal Health
        7.3.1 Saiba Animal Health Details
        7.3.2 Saiba Animal Health Major Business
        7.3.3 Saiba Animal Health VLP Vaccines Product and Services
        7.3.4 Saiba Animal Health VLP Vaccines Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Saiba Animal Health Recent Developments/Updates
        7.3.6 Saiba Animal Health Competitive Strengths & Weaknesses
    7.4 VBI
        7.4.1 VBI Details
        7.4.2 VBI Major Business
        7.4.3 VBI VLP Vaccines Product and Services
        7.4.4 VBI VLP Vaccines Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 VBI Recent Developments/Updates
        7.4.6 VBI Competitive Strengths & Weaknesses
    7.5 ARTES Biotechnology
        7.5.1 ARTES Biotechnology Details
        7.5.2 ARTES Biotechnology Major Business
        7.5.3 ARTES Biotechnology VLP Vaccines Product and Services
        7.5.4 ARTES Biotechnology VLP Vaccines Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 ARTES Biotechnology Recent Developments/Updates
        7.5.6 ARTES Biotechnology Competitive Strengths & Weaknesses
    7.6 VLP Therapeutics
        7.6.1 VLP Therapeutics Details
        7.6.2 VLP Therapeutics Major Business
        7.6.3 VLP Therapeutics VLP Vaccines Product and Services
        7.6.4 VLP Therapeutics VLP Vaccines Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 VLP Therapeutics Recent Developments/Updates
        7.6.6 VLP Therapeutics Competitive Strengths & Weaknesses
    7.7 POSVAX
        7.7.1 POSVAX Details
        7.7.2 POSVAX Major Business
        7.7.3 POSVAX VLP Vaccines Product and Services
        7.7.4 POSVAX VLP Vaccines Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 POSVAX Recent Developments/Updates
        7.7.6 POSVAX Competitive Strengths & Weaknesses
    7.8 Spybiotech
        7.8.1 Spybiotech Details
        7.8.2 Spybiotech Major Business
        7.8.3 Spybiotech VLP Vaccines Product and Services
        7.8.4 Spybiotech VLP Vaccines Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 Spybiotech Recent Developments/Updates
        7.8.6 Spybiotech Competitive Strengths & Weaknesses
    7.9 Optipharm Co. Ltd
        7.9.1 Optipharm Co. Ltd Details
        7.9.2 Optipharm Co. Ltd Major Business
        7.9.3 Optipharm Co. Ltd VLP Vaccines Product and Services
        7.9.4 Optipharm Co. Ltd VLP Vaccines Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 Optipharm Co. Ltd Recent Developments/Updates
        7.9.6 Optipharm Co. Ltd Competitive Strengths & Weaknesses
    7.10 H&Z Life Science
        7.10.1 H&Z Life Science Details
        7.10.2 H&Z Life Science Major Business
        7.10.3 H&Z Life Science VLP Vaccines Product and Services
        7.10.4 H&Z Life Science VLP Vaccines Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.10.5 H&Z Life Science Recent Developments/Updates
        7.10.6 H&Z Life Science Competitive Strengths & Weaknesses
    7.11 Gproan
        7.11.1 Gproan Details
        7.11.2 Gproan Major Business
        7.11.3 Gproan VLP Vaccines Product and Services
        7.11.4 Gproan VLP Vaccines Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.11.5 Gproan Recent Developments/Updates
        7.11.6 Gproan Competitive Strengths & Weaknesses
    7.12 Merck
        7.12.1 Merck Details
        7.12.2 Merck Major Business
        7.12.3 Merck VLP Vaccines Product and Services
        7.12.4 Merck VLP Vaccines Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.12.5 Merck Recent Developments/Updates
        7.12.6 Merck Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 VLP Vaccines Industry Chain
    8.2 VLP Vaccines Upstream Analysis
        8.2.1 VLP Vaccines Core Raw Materials
        8.2.2 Main Manufacturers of VLP Vaccines Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 VLP Vaccines Production Mode
    8.6 VLP Vaccines Procurement Model
    8.7 VLP Vaccines Industry Sales Model and Sales Channels
        8.7.1 VLP Vaccines Sales Model
        8.7.2 VLP Vaccines Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World VLP Vaccines Production Value by Region (2019, 2023 and 2030) & (USD Million)
    Table 2. World VLP Vaccines Production Value by Region (2019-2024) & (USD Million)
    Table 3. World VLP Vaccines Production Value by Region (2025-2030) & (USD Million)
    Table 4. World VLP Vaccines Production Value Market Share by Region (2019-2024)
    Table 5. World VLP Vaccines Production Value Market Share by Region (2025-2030)
    Table 6. World VLP Vaccines Production by Region (2019-2024) & (K Doses)
    Table 7. World VLP Vaccines Production by Region (2025-2030) & (K Doses)
    Table 8. World VLP Vaccines Production Market Share by Region (2019-2024)
    Table 9. World VLP Vaccines Production Market Share by Region (2025-2030)
    Table 10. World VLP Vaccines Average Price by Region (2019-2024) & (US$/Dose)
    Table 11. World VLP Vaccines Average Price by Region (2025-2030) & (US$/Dose)
    Table 12. VLP Vaccines Major Market Trends
    Table 13. World VLP Vaccines Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Doses)
    Table 14. World VLP Vaccines Consumption by Region (2019-2024) & (K Doses)
    Table 15. World VLP Vaccines Consumption Forecast by Region (2025-2030) & (K Doses)
    Table 16. World VLP Vaccines Production Value by Manufacturer (2019-2024) & (USD Million)
    Table 17. Production Value Market Share of Key VLP Vaccines Producers in 2023
    Table 18. World VLP Vaccines Production by Manufacturer (2019-2024) & (K Doses)
    Table 19. Production Market Share of Key VLP Vaccines Producers in 2023
    Table 20. World VLP Vaccines Average Price by Manufacturer (2019-2024) & (US$/Dose)
    Table 21. Global VLP Vaccines Company Evaluation Quadrant
    Table 22. World VLP Vaccines Industry Rank of Major Manufacturers, Based on Production Value in 2023
    Table 23. Head Office and VLP Vaccines Production Site of Key Manufacturer
    Table 24. VLP Vaccines Market: Company Product Type Footprint
    Table 25. VLP Vaccines Market: Company Product Application Footprint
    Table 26. VLP Vaccines Competitive Factors
    Table 27. VLP Vaccines New Entrant and Capacity Expansion Plans
    Table 28. VLP Vaccines Mergers & Acquisitions Activity
    Table 29. United States VS China VLP Vaccines Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 30. United States VS China VLP Vaccines Production Comparison, (2019 & 2023 & 2030) & (K Doses)
    Table 31. United States VS China VLP Vaccines Consumption Comparison, (2019 & 2023 & 2030) & (K Doses)
    Table 32. United States Based VLP Vaccines Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers VLP Vaccines Production Value, (2019-2024) & (USD Million)
    Table 34. United States Based Manufacturers VLP Vaccines Production Value Market Share (2019-2024)
    Table 35. United States Based Manufacturers VLP Vaccines Production (2019-2024) & (K Doses)
    Table 36. United States Based Manufacturers VLP Vaccines Production Market Share (2019-2024)
    Table 37. China Based VLP Vaccines Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers VLP Vaccines Production Value, (2019-2024) & (USD Million)
    Table 39. China Based Manufacturers VLP Vaccines Production Value Market Share (2019-2024)
    Table 40. China Based Manufacturers VLP Vaccines Production (2019-2024) & (K Doses)
    Table 41. China Based Manufacturers VLP Vaccines Production Market Share (2019-2024)
    Table 42. Rest of World Based VLP Vaccines Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers VLP Vaccines Production Value, (2019-2024) & (USD Million)
    Table 44. Rest of World Based Manufacturers VLP Vaccines Production Value Market Share (2019-2024)
    Table 45. Rest of World Based Manufacturers VLP Vaccines Production (2019-2024) & (K Doses)
    Table 46. Rest of World Based Manufacturers VLP Vaccines Production Market Share (2019-2024)
    Table 47. World VLP Vaccines Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 48. World VLP Vaccines Production by Type (2019-2024) & (K Doses)
    Table 49. World VLP Vaccines Production by Type (2025-2030) & (K Doses)
    Table 50. World VLP Vaccines Production Value by Type (2019-2024) & (USD Million)
    Table 51. World VLP Vaccines Production Value by Type (2025-2030) & (USD Million)
    Table 52. World VLP Vaccines Average Price by Type (2019-2024) & (US$/Dose)
    Table 53. World VLP Vaccines Average Price by Type (2025-2030) & (US$/Dose)
    Table 54. World VLP Vaccines Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 55. World VLP Vaccines Production by Application (2019-2024) & (K Doses)
    Table 56. World VLP Vaccines Production by Application (2025-2030) & (K Doses)
    Table 57. World VLP Vaccines Production Value by Application (2019-2024) & (USD Million)
    Table 58. World VLP Vaccines Production Value by Application (2025-2030) & (USD Million)
    Table 59. World VLP Vaccines Average Price by Application (2019-2024) & (US$/Dose)
    Table 60. World VLP Vaccines Average Price by Application (2025-2030) & (US$/Dose)
    Table 61. Medicago Basic Information, Manufacturing Base and Competitors
    Table 62. Medicago Major Business
    Table 63. Medicago VLP Vaccines Product and Services
    Table 64. Medicago VLP Vaccines Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 65. Medicago Recent Developments/Updates
    Table 66. Medicago Competitive Strengths & Weaknesses
    Table 67. Novavax Basic Information, Manufacturing Base and Competitors
    Table 68. Novavax Major Business
    Table 69. Novavax VLP Vaccines Product and Services
    Table 70. Novavax VLP Vaccines Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 71. Novavax Recent Developments/Updates
    Table 72. Novavax Competitive Strengths & Weaknesses
    Table 73. Saiba Animal Health Basic Information, Manufacturing Base and Competitors
    Table 74. Saiba Animal Health Major Business
    Table 75. Saiba Animal Health VLP Vaccines Product and Services
    Table 76. Saiba Animal Health VLP Vaccines Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 77. Saiba Animal Health Recent Developments/Updates
    Table 78. Saiba Animal Health Competitive Strengths & Weaknesses
    Table 79. VBI Basic Information, Manufacturing Base and Competitors
    Table 80. VBI Major Business
    Table 81. VBI VLP Vaccines Product and Services
    Table 82. VBI VLP Vaccines Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 83. VBI Recent Developments/Updates
    Table 84. VBI Competitive Strengths & Weaknesses
    Table 85. ARTES Biotechnology Basic Information, Manufacturing Base and Competitors
    Table 86. ARTES Biotechnology Major Business
    Table 87. ARTES Biotechnology VLP Vaccines Product and Services
    Table 88. ARTES Biotechnology VLP Vaccines Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 89. ARTES Biotechnology Recent Developments/Updates
    Table 90. ARTES Biotechnology Competitive Strengths & Weaknesses
    Table 91. VLP Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 92. VLP Therapeutics Major Business
    Table 93. VLP Therapeutics VLP Vaccines Product and Services
    Table 94. VLP Therapeutics VLP Vaccines Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 95. VLP Therapeutics Recent Developments/Updates
    Table 96. VLP Therapeutics Competitive Strengths & Weaknesses
    Table 97. POSVAX Basic Information, Manufacturing Base and Competitors
    Table 98. POSVAX Major Business
    Table 99. POSVAX VLP Vaccines Product and Services
    Table 100. POSVAX VLP Vaccines Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 101. POSVAX Recent Developments/Updates
    Table 102. POSVAX Competitive Strengths & Weaknesses
    Table 103. Spybiotech Basic Information, Manufacturing Base and Competitors
    Table 104. Spybiotech Major Business
    Table 105. Spybiotech VLP Vaccines Product and Services
    Table 106. Spybiotech VLP Vaccines Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 107. Spybiotech Recent Developments/Updates
    Table 108. Spybiotech Competitive Strengths & Weaknesses
    Table 109. Optipharm Co. Ltd Basic Information, Manufacturing Base and Competitors
    Table 110. Optipharm Co. Ltd Major Business
    Table 111. Optipharm Co. Ltd VLP Vaccines Product and Services
    Table 112. Optipharm Co. Ltd VLP Vaccines Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 113. Optipharm Co. Ltd Recent Developments/Updates
    Table 114. Optipharm Co. Ltd Competitive Strengths & Weaknesses
    Table 115. H&Z Life Science Basic Information, Manufacturing Base and Competitors
    Table 116. H&Z Life Science Major Business
    Table 117. H&Z Life Science VLP Vaccines Product and Services
    Table 118. H&Z Life Science VLP Vaccines Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 119. H&Z Life Science Recent Developments/Updates
    Table 120. H&Z Life Science Competitive Strengths & Weaknesses
    Table 121. Gproan Basic Information, Manufacturing Base and Competitors
    Table 122. Gproan Major Business
    Table 123. Gproan VLP Vaccines Product and Services
    Table 124. Gproan VLP Vaccines Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 125. Gproan Recent Developments/Updates
    Table 126. Merck Basic Information, Manufacturing Base and Competitors
    Table 127. Merck Major Business
    Table 128. Merck VLP Vaccines Product and Services
    Table 129. Merck VLP Vaccines Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 130. Global Key Players of VLP Vaccines Upstream (Raw Materials)
    Table 131. VLP Vaccines Typical Customers
    Table 132. VLP Vaccines Typical Distributors
List of Figure
    Figure 1. VLP Vaccines Picture
    Figure 2. World VLP Vaccines Production Value: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World VLP Vaccines Production Value and Forecast (2019-2030) & (USD Million)
    Figure 4. World VLP Vaccines Production (2019-2030) & (K Doses)
    Figure 5. World VLP Vaccines Average Price (2019-2030) & (US$/Dose)
    Figure 6. World VLP Vaccines Production Value Market Share by Region (2019-2030)
    Figure 7. World VLP Vaccines Production Market Share by Region (2019-2030)
    Figure 8. North America VLP Vaccines Production (2019-2030) & (K Doses)
    Figure 9. Europe VLP Vaccines Production (2019-2030) & (K Doses)
    Figure 10. China VLP Vaccines Production (2019-2030) & (K Doses)
    Figure 11. Japan VLP Vaccines Production (2019-2030) & (K Doses)
    Figure 12. VLP Vaccines Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World VLP Vaccines Consumption (2019-2030) & (K Doses)
    Figure 15. World VLP Vaccines Consumption Market Share by Region (2019-2030)
    Figure 16. United States VLP Vaccines Consumption (2019-2030) & (K Doses)
    Figure 17. China VLP Vaccines Consumption (2019-2030) & (K Doses)
    Figure 18. Europe VLP Vaccines Consumption (2019-2030) & (K Doses)
    Figure 19. Japan VLP Vaccines Consumption (2019-2030) & (K Doses)
    Figure 20. South Korea VLP Vaccines Consumption (2019-2030) & (K Doses)
    Figure 21. ASEAN VLP Vaccines Consumption (2019-2030) & (K Doses)
    Figure 22. India VLP Vaccines Consumption (2019-2030) & (K Doses)
    Figure 23. Producer Shipments of VLP Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2023
    Figure 24. Global Four-firm Concentration Ratios (CR4) for VLP Vaccines Markets in 2023
    Figure 25. Global Four-firm Concentration Ratios (CR8) for VLP Vaccines Markets in 2023
    Figure 26. United States VS China: VLP Vaccines Production Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 27. United States VS China: VLP Vaccines Production Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: VLP Vaccines Consumption Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. United States Based Manufacturers VLP Vaccines Production Market Share 2023
    Figure 30. China Based Manufacturers VLP Vaccines Production Market Share 2023
    Figure 31. Rest of World Based Manufacturers VLP Vaccines Production Market Share 2023
    Figure 32. World VLP Vaccines Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 33. World VLP Vaccines Production Value Market Share by Type in 2023
    Figure 34. HPV Vaccine
    Figure 35. Covid-19 Vaccine
    Figure 36. Hepatitis B Vaccine
    Figure 37. Others
    Figure 38. World VLP Vaccines Production Market Share by Type (2019-2030)
    Figure 39. World VLP Vaccines Production Value Market Share by Type (2019-2030)
    Figure 40. World VLP Vaccines Average Price by Type (2019-2030) & (US$/Dose)
    Figure 41. World VLP Vaccines Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 42. World VLP Vaccines Production Value Market Share by Application in 2023
    Figure 43. Government
    Figure 44. Medical Institution
    Figure 45. Others
    Figure 46. World VLP Vaccines Production Market Share by Application (2019-2030)
    Figure 47. World VLP Vaccines Production Value Market Share by Application (2019-2030)
    Figure 48. World VLP Vaccines Average Price by Application (2019-2030) & (US$/Dose)
    Figure 49. VLP Vaccines Industry Chain
    Figure 50. VLP Vaccines Procurement Model
    Figure 51. VLP Vaccines Sales Model
    Figure 52. VLP Vaccines Sales Channels, Direct Sales, and Distribution
    Figure 53. Methodology
    Figure 54. Research Process and Data Source

Companies Mentioned

Medicago
Novavax
Saiba Animal Health
VBI
ARTES Biotechnology
VLP Therapeutics
POSVAX
Spybiotech
Optipharm Co. Ltd
H&Z Life Science
Gproan
Merck